tradingkey.logo

Kamada Ltd

KMDA
8.210USD
+0.190+2.37%
Close 02/06, 16:00ETQuotes delayed by 15 min
473.56MMarket Cap
23.35P/E TTM

Kamada Ltd

8.210
+0.190+2.37%

More Details of Kamada Ltd Company

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Kamada Ltd Info

Ticker SymbolKMDA
Company nameKamada Ltd
IPO dateAug 01, 2005
CEOLondon (Amir)
Number of employees374
Security typeOrdinary Share
Fiscal year-endAug 01
Address2 Holtzman St., Science Park
CityREHOVOT
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7670402
Phone97289406472
Websitehttps://www.kamada.com/
Ticker SymbolKMDA
IPO dateAug 01, 2005
CEOLondon (Amir)

Company Executives of Kamada Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+1875.00%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical Director for Pulmonary Diseases
Vice President-Clinical Development and Medical Director for Pulmonary Diseases
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+1875.00%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
U.S.A
23.74M
50.49%
Israel
9.20M
19.56%
Latin America
6.44M
13.71%
Europe
3.86M
8.21%
Canada
2.39M
5.08%
Other
1.39M
2.96%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
Other
51.38%
Shareholders
Shareholders
Proportion
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
Other
51.38%
Shareholder Types
Shareholders
Proportion
Private Equity
38.29%
Corporation
4.86%
Investment Advisor
4.24%
Investment Advisor/Hedge Fund
3.03%
Hedge Fund
2.45%
Individual Investor
2.34%
Research Firm
1.61%
Pension Fund
0.14%
Bank and Trust
0.02%
Other
43.02%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
90
28.82M
49.96%
-1.10M
2025Q3
77
26.81M
46.48%
-3.11M
2025Q2
80
32.16M
55.76%
-1.16M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
2023Q3
106
34.53M
63.12%
+10.56M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
First Israel Mezzanine Investors Ltd.
22.08M
38.29%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.86%
-55.95K
-1.96%
Dec 31, 2024
Phoenix Investment and Finances Ltd
1.65M
2.87%
--
--
Sep 30, 2025
Renaissance Technologies LLC
871.98K
1.51%
+39.97K
+4.80%
Sep 30, 2025
Recanati (Leon Yehuda)
631.14K
1.09%
--
--
Dec 31, 2024
Tsur (David)
607.93K
1.05%
--
--
Dec 31, 2024
Wells Fargo Advisors
606.30K
1.05%
-4.17K
-0.68%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
449.03K
0.78%
+10.81K
+2.47%
Dec 31, 2025
Essex Investment Management Company, LLC
396.43K
0.69%
+72.60K
+22.42%
Sep 30, 2025
More Investment House Ltd.
269.67K
0.47%
-60.04K
-18.21%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Avantis International Small Cap Equity ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Dimensional International Core Equity Market ETF
0%
ARK Israel Innovative Technology ETF
0%
Avantis International Equity ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Schwab International Small-Cap Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Small Cap Value ETF
0%
Avantis International Small Cap Equity ETF
Proportion0.01%
DFA Dimensional International Small Cap ETF
Proportion0.01%
Dimensional International Core Equity Market ETF
Proportion0%
ARK Israel Innovative Technology ETF
Proportion0%
Avantis International Equity ETF
Proportion0%
Vanguard Total World Stock Index Fund
Proportion0%
Vanguard ESG International Stock ETF
Proportion0%
Schwab International Small-Cap Equity ETF
Proportion0%
DFA Dimensional International Core Equity 2 ETF
Proportion0%
DFA Dimensional International Small Cap Value ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI